NEOPHARM CO., LTD.

All News NeoPharm CO., LTD.

Equities

A092730

KR7092730001

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-15 pm EDT			5-day change	1st Jan Change
26,200 ^KRW	+5.01%		+3.15%	+1.35%

2023	NeoPharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2019	NeoPharm CO., LTD. announced that it has received KRW 31.970667276 billion in funding	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NeoPharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
NeoPharm CO., LTD. announced that it has received KRW 31.970667276 billion in funding	19-06-02	CI
NeoPharm CO., LTD. announced that it expects to receive KRW 31.970667276 billion in funding	19-05-23	CI
Gpower, inc. cancelled the acquisition of 0.27% stake in NeoPharm Co., Ltd. from Byungduk Park.	18-12-03	CI
Gpower, inc. agreed to acquire 0.27% stake in NeoPharm Co., Ltd. from Byungduk Park for approximately KRW 780 million.	17-12-07	CI
HOPE BIOSCIENCES, INC. Acquires Worldwide Rights to Novel MERTK/AXL Inhibitor from Neopharm Co. Ltd	17-02-01	CI
Han Bul Cosmetics Co., Ltd. and an individual completed the acquisition of 29.39% stake in Neopharm Co Ltd from Ahn, Yong-Chan and 7 individuals.	16-06-22	CI
Han Bul Cosmetics Co., Ltd. and an individual signed a contract to acquire 29.39% stake in Neopharm Co Ltd from Yong-Chan Ahn and 7 individuals for KRW 72.8 billion.	15-12-06	CI
Neopharm Co Ltd(KOSDAQ:A092730) added to S&P Global BMI Index	15-09-21	CI
LEO Pharma A/S Enters Supply and Distribution Agreement with NeoPharm Co., Ltd. on Non-Prescription Skin Care Solutions	15-06-03	CI
Neopharm Co Ltd's Equity Buyback announced on February 10, 2014 has expired.	15-02-08	CI
Tranche Update on Neopharm Co Ltd's Equity Buyback Plan announced on February 10, 2014.	14-05-11	CI
Neopharm Co Ltd authorizes a Buyback Plan.	14-02-09	CI
Neopharm Co Ltd announces an Equity Buyback for KRW 1,000 million worth of its shares.	14-02-09	CI
Tranche Update on Neopharm Co Ltd's Equity Buyback Plan announced on July 9, 2013	13-10-13	CI
Neopharm Co Ltd s Equity Buyback announced on July 9, 2013 has expired with 166,483 shares for KRW 1,007.08 million.	13-10-09	CI
Neopharm Co Ltd announces an Equity Buyback	13-07-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
A092730 Stock
News NeoPharm CO., LTD.

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW